CN100509849C - 可溶性人cd28分子检测试剂盒及其应用 - Google Patents
可溶性人cd28分子检测试剂盒及其应用 Download PDFInfo
- Publication number
- CN100509849C CN100509849C CNB200510038734XA CN200510038734A CN100509849C CN 100509849 C CN100509849 C CN 100509849C CN B200510038734X A CNB200510038734X A CN B200510038734XA CN 200510038734 A CN200510038734 A CN 200510038734A CN 100509849 C CN100509849 C CN 100509849C
- Authority
- CN
- China
- Prior art keywords
- monoclonal antibody
- cell
- people
- molecule
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510038734XA CN100509849C (zh) | 2005-04-07 | 2005-04-07 | 可溶性人cd28分子检测试剂盒及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB200510038734XA CN100509849C (zh) | 2005-04-07 | 2005-04-07 | 可溶性人cd28分子检测试剂盒及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1844150A CN1844150A (zh) | 2006-10-11 |
CN100509849C true CN100509849C (zh) | 2009-07-08 |
Family
ID=37063120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB200510038734XA Active CN100509849C (zh) | 2005-04-07 | 2005-04-07 | 可溶性人cd28分子检测试剂盒及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100509849C (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020183473A1 (en) * | 2019-03-14 | 2020-09-17 | Biond Biologics Ltd. | Small shedding blocking agents |
EP3937978A4 (en) * | 2019-03-14 | 2023-01-04 | Biond Biologics Ltd. | IMMUNOSUPPRESSION METHOD |
EP4069299A4 (en) * | 2019-12-02 | 2024-06-12 | Biond Biologics Ltd. | USING MMP INHIBITION |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102735841B (zh) * | 2011-04-13 | 2014-11-05 | 苏州卫生职业技术学院 | 一种测定Graves病患者血液中可溶性CD28含量的方法 |
CN105586318B (zh) * | 2016-01-25 | 2020-02-14 | 苏州大学附属第一医院 | 一种人可溶性icosl elisa试剂盒及其检测方法 |
AU2019328313A1 (en) | 2018-08-30 | 2021-02-25 | Immunitybio, Inc. | Single-chain chimeric polypeptides and uses thereof |
EP4103599A1 (en) * | 2020-02-11 | 2022-12-21 | HCW Biologics, Inc. | Methods of activating regulatory t cells |
US12024545B2 (en) | 2020-06-01 | 2024-07-02 | HCW Biologics, Inc. | Methods of treating aging-related disorders |
-
2005
- 2005-04-07 CN CNB200510038734XA patent/CN100509849C/zh active Active
Non-Patent Citations (4)
Title |
---|
5株鼠抗人CD28单克隆抗体的研制及生物学特性的研究. 孙中文等.细胞与分子免疫学杂志,第17卷第4期. 2001 |
5株鼠抗人CD28单克隆抗体的研制及生物学特性的研究. 孙中文等.细胞与分子免疫学杂志,第17卷第4期. 2001 * |
Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. ARUFFO A. 等.Proc. Natl. Acad. Sci. USA,Vol.84 . 1987 |
Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system. ARUFFO A. 等.Proc. Natl. Acad. Sci. USA,Vol.84 . 1987 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020183473A1 (en) * | 2019-03-14 | 2020-09-17 | Biond Biologics Ltd. | Small shedding blocking agents |
EP3937978A4 (en) * | 2019-03-14 | 2023-01-04 | Biond Biologics Ltd. | IMMUNOSUPPRESSION METHOD |
EP4069299A4 (en) * | 2019-12-02 | 2024-06-12 | Biond Biologics Ltd. | USING MMP INHIBITION |
Also Published As
Publication number | Publication date |
---|---|
CN1844150A (zh) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12077592B2 (en) | GPRC5D chimeric antigen receptors and cells expressing the same | |
CN100509849C (zh) | 可溶性人cd28分子检测试剂盒及其应用 | |
US5948893A (en) | Murine hybridoma and antibody binding to CD28 receptor secreted by the hybridoma and method of using the antibody | |
HintZen et al. | Characterization of the human CD27 ligand, a novel member of the TNF gene family. | |
KR100301146B1 (ko) | Cd4ob-세포항원에대한역-수용체및이에대한리간드 | |
Alderson et al. | Fas transduces activation signals in normal human T lymphocytes. | |
JP3675819B2 (ja) | Cd40に対する抗体 | |
KR100496063B1 (ko) | 신규단백질 및 그 제조방법 | |
Fromm et al. | Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy | |
JP2011079826A (ja) | Nkg2dの調節 | |
KR100850731B1 (ko) | P-셀렉틴 당단백질 리간드 1의 조절자 | |
Garni-Wagner et al. | 4-1BB Is Expressed on CD45RAhiROhiTransitional T Cell in Humans | |
SEWELL et al. | In vivo modulation of cytokine synthesis by intravenous immunoglobulin | |
US5688690A (en) | Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto | |
US6472510B1 (en) | CD40 receptor ligands | |
AU734853B2 (en) | Methods of prolonged suppression of humoral immunity | |
AU2002325333B2 (en) | NTB-A, a surface molecule involved in natural killer cells activity | |
Khunkaewla et al. | LFA-1-mediated leukocyte adhesion regulated by interaction of CD43 with LFA-1 and CD147 | |
Kotani et al. | Expression of functional Fas antigen on adult T-cell leukemia | |
CN110506058A (zh) | 免疫激动剂的施用路径 | |
KR20230022964A (ko) | 키메라 항원 발현 면역 세포의 시험관내 종양 살해 활성을 결정하기 위한 세포-기반 검정 | |
CN100509848C (zh) | 抗人ox40l单克隆抗体制备及应用 | |
CN100369933C (zh) | 抗人gl50单克隆抗体的制备及其应用 | |
AU743824B2 (en) | Use of anti-gp39 antibodies for treatment and/or reversal of lupus and associated kidney disease | |
Ozaki et al. | Antigen specificity of dual reactive T hybridomas determines the requirement for CD40 ligand-CD40 interactions. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: SUZHOU XUGUANG KEXING BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: SUZHOU UNIVERSITY Effective date: 20140725 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: SUZHOU, JIANGSU PROVINCE TO: 215000 SUZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140725 Address after: 215000, building 15, No. 8, Jinfeng Road, Suzhou hi tech Zone, Jiangsu, 303 Patentee after: Suzhou Xuguang Kexing Biological Technology Co. Ltd. Address before: No. 48 Renmin Road, Jiangsu, Suzhou Patentee before: Soochow University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191211 Address after: 215000 Room 302, building 12, No. 8, Jinfeng Road, Suzhou high tech Zone, Suzhou, Jiangsu Province Patentee after: Suzhou Xuguang Kexing antibody Biotechnology Co., Ltd Address before: 215000, building 15, No. 8, Jinfeng Road, Suzhou hi tech Zone, Jiangsu, 303 Patentee before: Suzhou Xuguang Kexing Biological Technology Co. Ltd. |